BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors

Abstract excerpt

BRAF is a component of the MAPK and PI3K/AKT/mTOR pathways that play a crucial role in cellular proliferation, differentiation, migration, and angiogenesis. Pediatric central nervous system tumors very often show mutations of the MAPK pathway, as demonstrated by next-generation sequencing (NGS), which now has an increasing role in cancer diagnostics. The MAPK mutated pathway in pediatric CNS tumors is the target...

Topics

Join the communities discussing this publication.

• Glioma Diagnosis and Treatment
• Cancer Mechanisms and Therapy
• Melanoma and MAPK Pathways